Countdown to #BIO2018 – Three days to go!
It’s an important time for the biotechnology industry. The therapies coming to the market and in clinical development today are unlike any we’ve seen in the history of medicine, and the M&A activity in the market is more exciting than ever: that’s why this year is primed to be an optimal time to build your pipeline. And with this in mind, there is no better place to scout for potential partners and assets to expand your portfolio than BIO 2018 in Boston, and no platform fac
Read more »